Strata Critical Medical, Inc.
5.22USD
-0.0900 (-1.69%)
Revenue
| (USD) | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|
| FY | 146.1M | 225.2M | 146.8M | 197.1M | 290.8M | 326.1M |
| Q1 | 26.6M | 45.3M | 51.5M | 35.9M | 67.4M | — |
| Q2 | 35.6M | 61.0M | 67.9M | 45.1M | 72.5M | — |
| Q3 | 45.7M | 71.4M | 36.1M | 49.3M | 72.7M | — |
| Q4 | 38.1M | 47.5M* | 36.4M* | 66.8M* | 78.3M | — |
Revenue
| (USD) | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|
| FY | -.380 | -.760 | -.350 | .500 | -.092 | .003 |
| Q1 | -.160 | -.140 | -.060 | -.040 | .030 | — |
| Q2 | .100 | -.170 | -.150 | -.050 | -.120 | — |
| Q3 | -.130 | .000 | -.030 | .700 | -.007 | — |
| Q4 | -.210 |
Fiscal period: Reported, Estimated. Reported figures: SEC filings (EDGAR). Estimates are sell-side consensus for periods that have not reported. Cells marked * were synthesized from the annual filing less the year-to-date figures, because the quarter was not filed on its own. Earnings per share are restated onto today's share basis, so a period before a stock split is comparable with the ones after it.
| -.462* |
| -.126* |
| -.108* |
| .010 |
| — |